Table 5.

QUARTIS scores at the end of the first year of SLIT with five-grass pollen tablet (n = 253)

QUARTIS domaina	Range of scoreb (min–max)	Score at study end (mean ± SD)
Compliance with SLIT	3–12	6.5 ± 2.1
Satisfaction with SLIT	4–20	8.8 ± 3.0
Motivation to continue SLITc	0–10	8.0 ± 2.4

QUARTIS Questionnaire sur l’Allergie Respiratoire Traitée par Immunothérapie Sublinguale, SD standard deviation, SLIT sublingual immunotherapy

^aLow values for compliance with SLIT and satisfaction with SLIT and high values for motivation to continue SLIT at study end represent favourable results

^bSum of the ratings of all items in the domain

^cMotivation to continue SLIT is an item in the domain “Continuation of SLIT” in questionnaire 2